Corcept Therapeutics Incorporated (CORT)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 679,589 | 638,835 | 596,243 | 547,864 | 506,705 | 461,679 | 421,614 | 529,584 | 501,842 | 473,364 | 442,326 | 407,811 | 375,806 | 540,229 | 522,675 | 510,802 | 523,338 | 489,680 | 453,698 | 409,489 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $679,589K)
= 0.00
The debt-to-capital ratio of Corcept Therapeutics Incorporated has consistently remained at 0.00 across all reported periods from March 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt as a source of capital during these periods. A debt-to-capital ratio of 0.00 implies that the company's capital structure is primarily equity financed, which may be viewed positively by investors and creditors as there is no significant financial leverage or debt-related risk involved. It suggests that the company may have a strong financial position and may not be subject to high interest payments or debt repayment pressure, potentially enhancing its financial stability and creditworthiness.
Peer comparison
Dec 31, 2024